what new

Tuesday, May 17, 2011

Jaringan Informasi Bersama Antar Sekolah

Satu produk aplikasi lokal open source untuk mengelola administrasi sekolah telah lahir, JIBAS namanya.JIBAS (Jaringan Informasi Bersama Antar Sekolah) yang diprakarsai oleh Yayasan Indonesia Membaca sungguh merupakan aplikasi yang komplet untuk mengelola administari sekolah. Ada berbagai macam module yang bisa digunakan untuk mengelola administrasi sekolah seperti Managemen Sekolah yang meliputi modul Akademik, Keuangan dan Perpustakaan.
Berbasiskan PHP dan MySQL yang open source membuat program aplikasi ini memungkinkan kita untuk memodifikasi dan mengembangkan sendiri sesuai kebutuhan.

Dari modul Jibas Akademik kita bisa mengelola :
.: Penerimaan Siswa Baru • Pendataan calon siswa • Penempatan calon siswa yang diterima di kelas baru • Laporan statistik penerimaan siswa baru
.: Guru & Pelajaran • Menentukan jenis-jenis pengujian pelajaran untuk setiap guru • Menentukan bobot penilaian setiap jenis pengujian untuk setiap guru • Pembuatan RPP (Rencana Program Pembelajaran) yang dapat diakses siswa
.: Pembuatan Jadwal Belajar Mengajar • Interaktif • Menghindari jadwal bentrok • Penyusunan Kalender Akademik
.: Pendataan Siswa • Pendataan siswa • Pindah kelas • Laporan Statistik Kesiswaan
.: Presensi Guru & Siswa • Presensi Harian atau Pelajaran • Laporan presensi: per siswa, per kelas, siswa yang tidak hadir, guru • Statistik Presensi per siswa dan kelas
.: Penilaian • Pendataan nilai ujian • Perhitungan otomatis rata-rata nilai per siswa dan per kelas • Perhitungan otomatis nilai rapor berdasarkan bobot pengujian • Pencetakan laporan nilai rapor siswa
.: Kenaikan & Kelulusan • Penempatan siswa di tingkat dan kelas yang baru • Pendataan Alumni
.: Mutasi Siswa • Pendataan siswa yang mutasi
Aplikasi ini masih terus dikembangkan dengan fitur-fitur yang ada saat ini, seperti managemen sekolah yang meliputi : akademik, keuangan, perpustakaan.
.: Terintegrasi dengan sistem keuangan, perpustakaan dan lainnya

Dari Module Keuangan :
.: Aman • Hanya pengguna yang memiliki akses yang dapat menggunakan aplikasi ini • Setiap perubahan data tercatat dalam Laporan Audit Data
.: Mudah & Terstruktur • Transaksi keuangan menggunakan standar akuntansi baku yang sederhana
.: Penerimaan Keuangan • Terintegrasi dengan sistem akademik • Pembayaran Iuran Wajib Siswa, Iuran Sukarela Siswa, Iuran Wajib Calon Siswa, Iuran Sukarela Calon Siswa dan Penerimaan Lainnya • Laporan Siswa Yang Menunggak • Laporan Pembayaran Siswa
.: Pengeluaran Keuangan • Pencatatan pembayaran keuangan, contohnya: Biaya Gaji, Administrasi, Operasional dan lainnya • Jenis-jenis pengeluaran dapat ditentukan pengguna • Laporan pengeluaran keuangan
.: Jurnal Umum • Untuk transaksi khusus selain penerimaan & pengeluaran rutin • Pencarian data jurnal umum
.: Laporan Akuntansi • Laporan Buku Besar • Neraca Percobaan • Laporan Laba-Rugi • Laporan Neraca • Laporan Arus Kas
.: Terintegrasi dengan sistem akademik, perpustakaan dan lainnya

Dari Modul Perpustakaan
.: Terintegrasi • Terintegrasi dengan aplikasi lain • Guru dapat melihat dan mencari buku melalui aplikasi JIBAS InfoGuru • Siswa dapat melihat dan mencari buku melalui aplikasi JIBAS InfoSiswa • Eksekutif Sekolah dapat melihat kondisi perpustakaan melalui JIBAS EMA
.: Pendataan Barang Pustaka • Katalog Pustaka • Penerbit • Penulis • Rak Tempat Penyimpanan
.: Peminjaman Pustaka • Peminjaman oleh siswa atau guru • Peminjaman oleh anggota lain di luar sekolah • Daftar peminjaman yang terlambat • Statistik peminjaman pustaka
.: Pengembalian Pustaka • Penerimaan Denda • Daftar Pengembalian Pustaka • Statistik Pengembalian Pustaka
.: Aktifitas Perpustakaan • Pendataan berbagai aktifitas perpustakaan

Saturday, April 30, 2011

Super Junior Chibi

Yesung

Eun hyuk

Kibum

Kyu hyun

Hangeng

Shindong

Donghae

Lee teuk

Siwon

Kang in

Heechul

Ryewook

Sungmin

Wednesday, March 16, 2011

H1N1 Vaccine (Benefits Vs. Risks for Individual)

The CDC has released 3.4 million doses of the H1N1,or swine flu,vaccine, which will be distributed throughout the 50 states. More than 251 million doses of the vaccine will be administered to Patients throughout flu seasons.

Although the panic factor surrounding the potential threat of a swine flu pandemic is

high, lethal cases of H1N1 have been relatively low. Out of the almost 30,000 cases of swine flu that have been reported, most cases are mild. As of early September 127 people in the U.S. had died of swine flu. Pat El-Hinnawy, H1N1 Public Affairs Specialist for the FDA, says :

"So far, [the H1N1 virus] has not shown a very high virulence or a very high mutation rate. For most of the people who get it, it's not a very severe set of symptoms."

That's causing some experts to question the necessity of getting vaccinated. Dr. Arthur

Douville, a neurologist from Los Gatos, California, asked, "How widely should we vaccinate against an influenza virus that is relatively modest in its effects, and which the exact extent of the pandemic we can't really predict?" Good question. When it comes to public health, there's a fine line between harm and safety.

Swine flu is not a new virus. In 1976 there was a spread of infections of the same virus and the government set a large vaccination program in motion. Millions of Americans were vaccinated, but many suffered adverse events such as Guillain-Barre Syndrome. GBS is a neurological disorder where nerve damage can result in paralysis and loss of muscle function, potentially causing death. The vaccination program was abandoned after three months.

Vaccination technology has come a long way since the late 70's, as Dr. Jonathon Fielding, a public health officer for the County of Los Angeles, points out.

"We have been making vaccines for 33 years since then. I think the rate of complications of vaccine administration is very very small, and the benefits are so great compared to the very small risk."

Today's H1N1 vaccine is identical to the seasonal influenza vaccine distributed every year, except that instead of injecting the flu virus, H1N1 is injected. Both the FDA and CDC say the risks are similar to those associated with getting a vaccine for the common flu. Arleen Porcell-Pharr, a Public Affairs Specialist for the CDC, says "We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have very good safety track records."

Samantha Ellinwood, a 1st year medical student at UC Davis believes strongly in her decision to get vaccinated, not only because her school requires it, but because she sees it as part of her obligation as a member of the health-care profession. "Honestly, the risks involved are a lot lower in getting the vaccine than not getting it," she said. "I am in a position where I could get a lot of people sick, especially people who are immune compromised. It's important for people like me to get vaccinated."

However not everyone is so confident in the safety of the new vaccine for every member of society. Dr. Douville said that he is telling some patients not to get vaccinated. "If you already have demonstrated that you have some risk of getting a Guillain-Barre like illness, then maybe we shouldn't take that risk. It depends on the risk of the disease. So far, H1N1 is relatively modest risk."

Some critics say the new vaccine has not been thoroughly tested. There is currently a study on the H1N1 vaccine going on in Denver, CO that has yet to publish results. Jeffry John Aufderheide, who works for VacTruth, a watchdog group, says it's too early to be widely distributing the vaccine.

"The trials didn't even start until last week and they are already calling it safe. How are they able to say something is safe without testing it?"

The CDC is confident in the safety of the H1N1 vaccine because it is very similar to the vaccine for the common flu, which has proven not to be dangerous to the majority of the population. The CDC currently recommends that pregnant women, caregivers, healthcare and medical personnel, be among the first to receive the 2009 H1N1 vaccine. Additionally recommended for vaccination are all people between the ages of 6 months and 24 years as well as people ages 25 to 65 with health conditions associated with medical complications from influenza. The inoculation also comes in the form of a nasal spray, which can be risky for pregnant women and people with chronic medical conditions.

Sunday, February 20, 2011

Google Bengsrek

GudangRocker.Blogspot.com, ganti aja ya namanya menjadi GrobakRogol.Blogshit.com///
ah shiiiittt.... gw ga tau mo gimana lagi, yang jelas gw jengkel banget sekarang sama yang namanya GOOGLE. Gimana ga jengkel, bermula saat masih di Temanggung ( 22 Oktober 2008 ) gw buat nih blog pertama kali buat iseng aja, hasilnya menyenangkan juga bisa share sama orang lain. Tapi ketika awal tahun 2010, gw diiming-imingi buat daftar google adsense. Langsung dah gw daftar, kemudian approved sama google.

Nha dari situ sampe akhir desember, ya kira-kira satu tahunan lah... pendapatan gw hampir $100. yang namanya dapet duit dari internet meskipun dikit tapi bikin penasaran juga. EEEE.... gak taunya... pas buka account googleAds gw, tiba-tiba kayak gini :

Yup,,,, Congratulation to me. GW resmi DIBANNED!

skrin sut nya :

Males gw jadinya lihat logo ini :

wes ah.. bubar...

Tapi gpp lah... gw ngga ngarep banget sama tuh duit, Alhamdulillah... Duitnya udah di ganti sama Yang Maha Kuasa dengan gaji selama 7 hari pertama gw bekerja di Tangerang saat ini.

[pic]